Jing Zou

9.8k total citations · 4 hit papers
67 papers, 3.6k citations indexed

About

Jing Zou is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Animal Science and Zoology. According to data from OpenAlex, Jing Zou has authored 67 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Infectious Diseases, 35 papers in Public Health, Environmental and Occupational Health and 13 papers in Animal Science and Zoology. Recurrent topics in Jing Zou's work include Mosquito-borne diseases and control (35 papers), Viral Infections and Vectors (26 papers) and SARS-CoV-2 and COVID-19 Research (22 papers). Jing Zou is often cited by papers focused on Mosquito-borne diseases and control (35 papers), Viral Infections and Vectors (26 papers) and SARS-CoV-2 and COVID-19 Research (22 papers). Jing Zou collaborates with scholars based in United States, China and Singapore. Jing Zou's co-authors include Pei‐Yong Shi, Xuping Xie, Hongjie Xia, Scott C. Weaver, Xianwen Zhang, Antonio E. Muruato, Chao Shan, Ping Ren, Vineet D. Menachery and Chaitanya Kurhade and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Jing Zou

65 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera

2021 383 citations Xuping Xie, Yang Liu et al. Nature Medicine profile →
Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster

2022 251 citations Chaitanya Kurhade, Jing Zou et al. Nature Medicine profile →
An evolutionary NS1 mutation enhances Zika virus evasion of host interferon induction

2018 227 citations Hongjie Xia, Chao Shan et al. Nature Communications profile →
BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants

2021 212 citations Jianying Liu, Yang Liu et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jing Zou United States	32	2.9k	1.6k	622	459	353	67	3.6k
Pragya D. Yadav India	32	2.7k 0.9×	1.2k 0.7×	721 1.2×	502 1.1×	185 0.5×	196	3.8k
Kenneth S. Plante United States	26	2.1k 0.7×	1.2k 0.7×	469 0.8×	303 0.7×	227 0.6×	61	2.8k
Michael R. Holbrook United States	38	3.4k 1.2×	1.6k 1.0×	661 1.1×	973 2.1×	224 0.6×	107	4.6k
Ramesh Jadi United States	21	3.5k 1.2×	1.2k 0.7×	627 1.0×	784 1.7×	202 0.6×	40	4.2k
Etienne Simon‐Lorière France	30	1.9k 0.7×	1.1k 0.7×	740 1.2×	539 1.2×	319 0.9×	67	3.1k
Michael K. Lo United States	31	2.1k 0.7×	866 0.5×	432 0.7×	1.6k 3.5×	208 0.6×	66	3.1k
Antonio E. Muruato United States	20	2.1k 0.7×	1.5k 0.9×	290 0.5×	608 1.3×	172 0.5×	31	2.5k
Leah C. Katzelnick United States	27	2.8k 1.0×	2.4k 1.5×	252 0.4×	545 1.2×	83 0.2×	51	3.9k
Xuping Xie United States	49	6.0k 2.1×	3.3k 2.0×	1.5k 2.5×	1.0k 2.2×	710 2.0×	132	7.8k
Jorge L. Muñoz‐Jordán United States	38	3.5k 1.2×	4.2k 2.6×	482 0.8×	837 1.8×	118 0.3×	117	5.3k

Countries citing papers authored by Jing Zou

Since Specialization

Citations

This map shows the geographic impact of Jing Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Zou more than expected).

Fields of papers citing papers by Jing Zou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Zou. The network helps show where Jing Zou may publish in the future.

Co-authorship network of co-authors of Jing Zou

This figure shows the co-authorship network connecting the top 25 collaborators of Jing Zou. A scholar is included among the top collaborators of Jing Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Zou. Jing Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hu, Yanping, Jing Zou, Jason Yeung, et al.. (2025). Comparative analysis of replication and immune evasion among SARS-CoV-2 subvariants BA.2.86, JN.1, KP.2, and KP.3. mBio. 16(6). e0350324–e0350324. 2 indexed citations

Zou, Jing, et al.. (2025). A dual-reporter HCoV-OC43 for coronavirus biology and countermeasure development. Antiviral Research. 244. 106306–106306.

Xia, Hongjie, Jason Yeung, Birte Kalveram, et al.. (2023). Cross-neutralization and viral fitness of SARS-CoV-2 Omicron sublineages. Emerging Microbes & Infections. 12(1). e2161422–e2161422. 12 indexed citations

Zou, Jing, Xuping Xie, Mingru Liu, Pei‐Yong Shi, & Ping Ren. (2022). Neutralization Titers in Vaccinated Patients with SARS-CoV-2 Delta Breakthrough Infections. mBio. 13(4). e0199622–e0199622. 7 indexed citations

Zou, Jing, Hongjie Xia, Xuping Xie, et al.. (2022). Neutralization against Omicron SARS-CoV-2 from previous non-Omicron infection. Nature Communications. 13(1). 852–852. 79 indexed citations

Kurhade, Chaitanya, Jing Zou, Hongjie Xia, et al.. (2022). Neutralization of Omicron BA.1, BA.2, and BA.3 SARS-CoV-2 by 3 doses of BNT162b2 vaccine. Nature Communications. 13(1). 3602–3602. 41 indexed citations

Liu, Yang, Xianwen Zhang, Jianying Liu, et al.. (2022). A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions. Nature Communications. 13(1). 4337–4337. 62 indexed citations

Liu, Jianying, Yang Liu, Hongjie Xia, et al.. (2022). BNT162b2-elicited neutralization of Delta plus, Lambda, Mu, B.1.1.519, and Theta SARS-CoV-2 variants. npj Vaccines. 7(1). 41–41. 6 indexed citations

Zou, Jing, Chaitanya Kurhade, Hongjie Xia, et al.. (2022). Cross-neutralization of Omicron BA.1 against BA.2 and BA.3 SARS-CoV-2. Nature Communications. 13(1). 2956–2956. 22 indexed citations

10.

Li, Yi, Shuizhen Shi, Chao Shan, et al.. (2021). Zika virus induces neuronal and vascular degeneration in developing mouse retina. Acta Neuropathologica Communications. 9(1). 97–97. 15 indexed citations

11.

Liu, Jianying, Yang Liu, Hongjie Xia, et al.. (2021). BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants. Nature. 596(7871). 273–275. 212 indexed citations breakdown →

12.

Zou, Jing, Xuping Xie, Camila R. Fontes-Garfias, et al.. (2021). The effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralization. npj Vaccines. 6(1). 44–44. 29 indexed citations

13.

Xie, Xuping, Yang Liu, Jianying Liu, et al.. (2021). Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera. Nature Medicine. 27(4). 620–621. 383 indexed citations breakdown →

14.

Xu, Pei, Junling Gao, Chao Shan, et al.. (2021). Inhibition of innate immune response ameliorates Zika virus-induced neurogenesis deficit in human neural stem cells. PLoS neglected tropical diseases. 15(3). e0009183–e0009183. 8 indexed citations

15.

Zhang, Xianwen, Yang Liu, Jianying Liu, et al.. (2021). A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence. Cell. 184(8). 2229–2238.e13. 52 indexed citations

16.

Xie, Xuping, Antonio E. Muruato, Xianwen Zhang, et al.. (2020). A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19. Nature Communications. 11(1). 142 indexed citations

17.

Zhang, Xianwen, Xuping Xie, Hongjie Xia, et al.. (2019). Zika Virus NS2A-Mediated Virion Assembly. mBio. 10(5). 66 indexed citations

18.

Shan, Chao, Xuping Xie, Jing Zou, et al.. (2018). Using a Virion Assembly-Defective Dengue Virus as a Vaccine Approach. Journal of Virology. 92(21). 16 indexed citations

19.

Xie, Xuping, Yujiao Yang, Antonio E. Muruato, et al.. (2017). Understanding Zika Virus Stability and Developing a Chimeric Vaccine through Functional Analysis. mBio. 8(1). 69 indexed citations

20.

Li, Yan, Youngmee Kim, Jing Zou, et al.. (2015). Secondary structure and membrane topology of dengue virus NS4B N-terminal 125 amino acids. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1848(12). 3150–3157. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact